{
    "Trade/Device Name(s)": [
        "HSV 1 & 2 ELITe MGB Kit",
        "HSV 1&2 ELITe MGB Assay",
        "ELITe InGenius"
    ],
    "Submitter Information": "ELITechGroup Inc. Molecular Diagnostics",
    "510(k) Number": "K180559",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151906"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PGI",
        "OOI"
    ],
    "Summary Letter Date": "January 17, 2018",
    "Summary Letter Received Date": "March 1, 2018",
    "Submission Date": "September 25, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3309"
    ],
    "Regulation Name(s)": [
        "Herpes virus nucleic acid-based cutaneous and mucocutaneous lesion panel"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Herpes Simplex Virus 1 DNA",
        "Herpes Simplex Virus 2 DNA"
    ],
    "Specimen Type(s)": [
        "Cutaneous lesion swab",
        "Mucocutaneous lesion swab"
    ],
    "Specimen Container(s)": [
        "Universal Transport Medium (UTM)",
        "M4",
        "M4RT",
        "M5",
        "M6"
    ],
    "Instrument(s)/Platform(s)": [
        "ELITe InGenius system"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Automated sample extraction",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Qualitative PCR",
        "Nucleic acid extraction",
        "Real-time detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Analyzer",
        "Extraction kit",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for HSV 1&2 ELITe MGB real-time PCR assay for detection and differentiation of HSV-1 and HSV-2 DNA in lesion swabs using the ELITe InGenius system",
    "Indications for Use Summary": "A real-time PCR-based qualitative in vitro diagnostic test for direct detection and differentiation of HSV-1 and HSV-2 DNA in cutaneous or mucocutaneous lesion swab specimens from symptomatic patients to aid in differential diagnosis of HSV infections; not cleared for cerebrospinal fluid, prenatal, or blood/blood product screening.",
    "fda_folder": "Microbiology"
}